Andrea Spencer, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Andrea Spencer, MD is an Assistant Professor of Psychiatry at the Chobanian and Avedisian School of Medicine. Her primary research interest is improving treatment for ADHD in primary care settings. She is Board Certified in both Child and Adult Psychiatry after completing a dual residency at Mass General Hospital and McLean Hospital. She stayed at Mass General Hospital to work with Dr. Joseph Biederman in the Bressler Program for Autism at MGH. Dr. Spencer's research has been bolstered by grants such as the Dupont Warren and Livingston Awards. Outside of the medical field Dr. Spencer, a music major during her undergrad, plays viola with the Longwood Symphony Orchestra.

Publications

  • Published 1/1/2019

    Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Psychopharmacol. 2019 Jan/Feb; 39(1):28-38. PMID: 30566416.

    Read at: PubMed

  • Published 1/1/2019

    Spencer AE, Chiang C, Plasencia N, Biederman J, Sun Y, Gebara C, Jellinek M, Murphy JM, Zima BT. Utilization of Child Psychiatry Consultation Embedded in Primary Care for an Urban, Latino Population. J Health Care Poor Underserved. 2019; 30(2):637-652. PMID: 31130542.

    Read at: PubMed

  • Published 7/13/2018

    Spencer AE, Plasencia N, Sun Y, Lucke C, Haile H, Cronin R, Faraone SV, Jellinek M, Murphy JM, Biederman J. Screening for Attention-Deficit/Hyperactivity Disorder and Comorbidities in a Diverse, Urban Primary Care Setting. Clin Pediatr (Phila). 2018 10; 57(12):1442-1452. PMID: 30003797.

    Read at: PubMed

  • Published 3/1/2018

    Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Feinberg L, Kassabian S, Storch B, Biederman J. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone. J Clin Psychiatry. 2018 Mar/Apr; 79(2). PMID: 29617066.

    Read at: PubMed

  • Published 1/1/2018

    Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Biederman J. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone. J Clin Psychiatry. 2018 Jan/Feb; 79(1). PMID: 28640990.

    Read at: PubMed